Jump to page content Accessibility
News, views and contacts from the global Drugdevelopment industry
Login to drugdevelopment-technology.com Log in or Register
  • Home
  • Products & Services
  • Company A - Z
  • Projects
  • Features
  • Videos
  • White Papers
  • News
  • Events
  • Advertise With Us
Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Cetilistat - Investigational Drug for Obesity



Metabolic syndrome

Obesity is included in the ATP III diagnostic criteria for metabolic syndrome.

  • Metabolic syndrome
    Obesity is included in the ATP III diagnostic criteria for metabolic syndrome.
  • Obesity contributory factors
    Figures from the American Heart Association suggest 20% to 25% of US adults...
  • Clinical obesity
    Clinical obesity is usually defined as a BMI of greater than 30.
  • UK rates of obesity
    Rates of obesity in the UK increased significantly during the 1990s and...
  • Lipase inhibitors
    Various therapeutic strategies have been explored for the treatment of...

Back to Project Details



Related Projects

Ariflo (Cilomilast) - Oral PDE-IV Inhibitor for
Ariflo (cilomilast) is an oral selective phosphodiesterase (PDE) IV...

Sativex - Investigational Cannabis-Based treatment for Pain and Multiple Sclerosis
Developed by GW Pharmaceuticals, Sativex is a whole plant medicinal...

Capravirine - Anti-Retroviral Drug
Developed by Pfizer Global Research and Development, capravirine is...

Acomplia (Rimonabant) - Investigational Agent for
Developed by Sanofi-Aventis, Acomplia (rimonabant) is a selective...

Tarceva - Small Molecule
Tarceva (erlotinib) is an oral anti-cancer drug developed by...

See all projects


Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2011 Net Resources International, a trading division of SPG Media Limited.